Diagnostic Utility of Bedside Cyst Fluid Glucose for Identifying Mucinous Pancreatic Cysts: A Prospective Study
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S994
DOI: 10.1055/s-0046-1822918 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von M Aggarwal und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
To evaluate the diagnostic accuracy of bedside cyst fluid glucose for identifying mucinous pancreatic cysts and to assess its agreement with laboratory glucose measurements.
Methods
In this prospective study, consecutive patients undergoing endoscopic ultrasound-guided cyst fluid aspiration for pancreatic cystic lesions during the study period (February 2022 – January 2026) were enrolled. Cyst fluid glucose was measured at the bedside using a glucometer and compared with laboratory glucose measurements. The reference diagnosis was established using cytology, biopsy, surgical histopathology, and clinical follow-up. Receiver operating characteristic (ROC) analysis was performed to determine the diagnostic performance and optimal cutoff value of cyst fluid glucose for identifying mucinous cysts. Agreement between bedside and laboratory glucose measurements was evaluated using correlation and Bland–Altman analysis.
Results
A total of 56 patients with pancreatic cystic lesions were included. Bedside cyst fluid glucose demonstrated good diagnostic accuracy for identifying mucinous cysts with an area under the ROC curve of 0.76. The optimal cutoff value was 67 mg/dL, which yielded a sensitivity of 85% and specificity of 68% for differentiating mucinous from non-mucinous cysts. Bedside and laboratory glucose measurements showed excellent correlation (r=0.96). Bland–Altman analysis demonstrated good agreement between the two methods with minimal bias.
Conclusions
Bedside cyst fluid glucose measurement is a rapid, inexpensive, and reliable method for distinguishing mucinous from non-mucinous pancreatic cysts. Its strong agreement with laboratory glucose measurements supports its use as a practical point-of-care diagnostic tool in the evaluation of pancreatic cystic lesions. (NCT05962723) Publication History Article published online: 06 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Aggarwal, M., Lakhtakia, S., Nabi, Z., & Reddy, D. N. (2026). Diagnostic Utility of Bedside Cyst Fluid Glucose for Identifying Mucinous Pancreatic Cysts: A Prospective Study. Endoscopy, 58(S 03 S 03), S994. https://doi.org/10.1055/s-0046-1822918
Vancouver
Aggarwal M, Lakhtakia S, Nabi Z, Reddy DN. Diagnostic Utility of Bedside Cyst Fluid Glucose for Identifying Mucinous Pancreatic Cysts: A Prospective Study. Endoscopy. 2026;58(S 03 S 03):S994. doi:10.1055/s-0046-1822918
BibTeX
@article{Aggarwal2026,
author = {Aggarwal, M and Lakhtakia, S and Nabi, Z and Reddy, D N},
title = {Diagnostic Utility of Bedside Cyst Fluid Glucose for Identifying Mucinous Pancreatic Cysts: A Prospective Study},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S994},
doi = {10.1055/s-0046-1822918}
}
EUVIMED